Detalles de la búsqueda
1.
Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection.
Clin Infect Dis
; 78(4): 833-841, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37823484
2.
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer ß-lactam or ß-lactam/ß-lactamase inhibitor-, polymyxin- or aminoglycoside-containing regimen.
J Antimicrob Chemother
; 79(1): 82-95, 2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962080
3.
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S305-S313, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843118
4.
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
Clin Infect Dis
; 77(Suppl 4): S295-S304, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843115
5.
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam.
Antimicrob Agents Chemother
; 66(7): e0025622, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727059
6.
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.
Antimicrob Agents Chemother
; 66(12): e0093522, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394316
7.
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.
Antimicrob Agents Chemother
; 66(12): e0093622, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394326
8.
Considerations for the Use of Phage Therapy in Clinical Practice.
Antimicrob Agents Chemother
; 66(3): e0207121, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041506
9.
Determination of plasma protein binding of dalbavancin.
J Antimicrob Chemother
; 77(7): 1899-1902, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488862
10.
Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
Clin Infect Dis
; 72(9): 1497-1501, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740042
11.
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections.
Clin Infect Dis
; 73(11): e4560-e4567, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32716506
12.
The Pharmacodynamic-Toxicodynamic Relationship of AUC and Cmax in Vancomycin-Induced Kidney Injury in an Animal Model.
Antimicrob Agents Chemother
; 65(3)2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318004
13.
Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships.
Antimicrob Agents Chemother
; 65(10): e0106021, 2021 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339278
14.
Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).
Antimicrob Agents Chemother
; 65(3)2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33168615
15.
The case for precision dosing: medical conservatism does not justify inaction.
J Antimicrob Chemother
; 76(7): 1661-1665, 2021 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33843994
16.
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Clin Infect Dis
; 71(6): 1361-1364, 2020 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32658968
17.
Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-ß-Lactamase-1.
Clin Infect Dis
; 71(4): 1095-1098, 2020 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802119
18.
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).
Clin Infect Dis
; 70(8): 1536-1545, 2020 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157370
19.
Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32718970
20.
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model.
J Antimicrob Chemother
; 75(9): 2622-2632, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32464664